ID   BB49-EBV
AC   CVCL_VU51
SY   BB49EBV
DR   Cell_Model_Passport; SIDM01722
DR   DepMap; ACH-002343
DR   Wikidata; Q93423379
RX   PubMed=9271594;
RX   PubMed=20164919;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Ludwig Institute for Cancer Research, Brussels Branch; Brussels; Belgium.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1077 ! BB49-HNC
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
RX   PubMed=9271594; DOI=10.1084/jem.186.5.785;
RA   Mandruzzato S., Brasseur F., Andry G., Boon T., van der Bruggen P.;
RT   "A CASP-8 mutation recognized by cytolytic T lymphocytes on a human
RT   head and neck carcinoma.";
RL   J. Exp. Med. 186:785-793(1997).
//
RX   PubMed=20164919; DOI=10.1038/nature08768;
RA   Bignell G.R., Greenman C.D., Davies H., Butler A.P., Edkins S.,
RA   Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S.,
RA   Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T.,
RA   Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.;
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//